🔎 Trials Near Me

Home › Neuroendocrine Tumors › Pennsylvania

Pag-aaral pangklinika para sa Neuroendocrine Tumors sa Pennsylvania

11 pag-aaral para sa Neuroendocrine Tumors ang naghahanap ng mga kalahok sa mga site sa Pennsylvania.

Mga Lungsod sa Pennsylvania

Opisyal na teksto ng pag-aaral (English)

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

  • University of Pennsylvania, Philadelphia
  • University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06943755

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

  • The Children's Hospital of Philadelphia (CHOP), Philadelphia
Nagre-recruitPhase 1
24 Months – 18 Years · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06441331

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

  • Hospital of the University of Pennsylvania, Philadelphia
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07087054

Project: Every Child for Younger Patients With Cancer

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Geisinger Medical Center, Danville
  • Penn State Children's Hospital, Hershey
  • at 4 pa
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 25 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT02402244

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

  • Crinetics Study Site, Philadelphia
  • Crinetics Study Site, Philadelphia
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT07129252

Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

  • Fox Chase Cancer Center, Philadelphia
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT05263050

CapTemY90 for Grade 2/3 NET Liver Metastases

  • University of Pennsylvania, Philadelphia
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 4, 2026 · NCT04339036

Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

  • University of Pennsylvania, Philadelphia
Nagre-recruitPhase 1/2
Edad 20 hanggang 99 · Lahat ng kasarian · Na-update Abr 20, 2026 · NCT02174549

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

  • University of Pennsylvania, Philadelphia
Nagre-recruitPhase 1/2
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Ene 29, 2026 · NCT06055439

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

  • Penn State Hershey Medical Center, Hershey
  • Albert Einstein Healthcare Network, Philadelphia
Nagre-recruitPhase 4
Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Ene 22, 2026 · NCT04373564

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Philadelphia
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.